Clinical Trials Logo

Clinical Trial Summary

The objectives of this non-significant risk (NSR) study are to evaluate the safety of the short term placement of the Basmati Injectrode for up to 28 days and the efficacy of conducting electrical current to stimulate subcutaneous nerves on the explant date just prior to explant.


Clinical Trial Description

This was a prospective, single-center, single-arm, non-randomized study design. A sample of 10 study participants were enrolled into the study, and provided with the placement of a Basmati Injectrode insert with a maximal placement duration of up to 28 days. Subjects who were selected to participate in the trial were healthy volunteers adults with ages 18 years and older without any preexisting condition indicated for treatment. Each subject was followed during the trial period of approximately 45+/-2 days. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04672096
Study type Interventional
Source Neuronoff, Inc
Contact
Status Completed
Phase N/A
Start date December 4, 2020
Completion date May 21, 2021

See also
  Status Clinical Trial Phase
Completed NCT01923285 - A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain N/A